# Optimise, Maximise and FOMO in a Quant-Trading System

Version: 1.0  
Export date: 15 October 2026 (SGT)

Export note: The previous response is reproduced below without editing, including its original timestamp, paragraph identifiers, tables, mathematics, coding prompt and citation markers. Chat-specific citation markers may not resolve outside ChatGPT; direct links to their GitHub source files are supplied after the original response. This export checks content preservation, not the factual accuracy of the original assessment.

---

<!-- BEGIN ORIGINAL RESPONSE -->
№ 1 - 14-10 '26 21:38 SGT

**Yes, Adrian - the words express different intentions, but none is a sufficient coding specification.** The important distinction is not “optimise is prudent; maximise is reckless”. It is **what the system is trying to improve, what it must not sacrifice, and what evidence demonstrates that the implementation meets those requirements**. Mathematical optimisation can include maximisation, while LLM development needs specific, measurable criteria and evaluations. ([web.stanford.edu](https://www.web.stanford.edu/~boyd/papers/cvx_opt_graph_lapl_eigs.html?utm_source=chatgpt.com)) [§1.5]

The matching assessment is in **`bot_trade_biomimetic_survival_contract.md`, Section 3.0, row 4**, headed “Optimizes rather than maximizes”. Its current wording refers to net-of-cost bootstrap lower-bound expectancy rather than raw win rate or trade count. I checked the two files at repository snapshot `42bbabc`. The full sentence you pasted, including the explanation about a 25% win rate, is not the wording I found in that matching passage. fileciteturn7file0L2-L6 [§1.6]

## 1. What the three terms should mean to a coding LLM

| Term | Meaning that should be specified | What must not be assumed |
|---|---|---|
| **Optimise** | Seek the best available settings for a defined objective, within defined constraints. | That “optimise” automatically means conservative, profitable or robust. It might instead mean reducing latency, increasing win rate or improving a backtest score. [§1.7] |
| **Maximise** | Make a specified quantity as large as possible, within the permitted constraints. | That maximisation necessarily means excessive trading or risk. Maximising a conservative net-performance estimate **subject to hard risk limits** is a legitimate optimisation formulation. [§1.8] |
| **FOMO** | Literally, fear of missing out. In a software specification, use it as a label for particular behaviours to prevent, not as a measurable objective. | That “avoid FOMO” tells the coder exactly which entries, retries, position sizes or re-arming decisions to block. [§1.9] |

The mathematical distinction is straightforward: **maximising \(f(x)\) is equivalent to minimising \(-f(x)\), over the same permitted choices**. Both are optimisation. Stanford’s optimisation work explicitly includes maximisation and minimisation under constraints; its risk-constrained Kelly research also demonstrates how growth objectives can be combined with drawdown constraints, under the research model’s assumptions. ([web.stanford.edu](https://www.web.stanford.edu/~boyd/papers/cvx_opt_graph_lapl_eigs.html?utm_source=chatgpt.com)) [§1.10]

FOMO belongs to a different category: human decision-making. The SEC uses it to describe pressure to participate in an investment opportunity for fear of missing it. For your system, I would translate that into **observable, testable behaviours**, rather than attributing fear to the software. ([investor.gov](https://www.investor.gov/additional-resources/spotlight/formerdirectorlorischock-directors-take/say-no-go-fomo?utm_source=chatgpt.com)) [§1.11]

For example, these would be *proposed anti-FOMO requirements*: do not relax entry thresholds merely because no trades occurred; do not chase an expired signal after price has moved; do not increase size merely to recover a missed opportunity; and do not restore full-risk trading merely because a cooldown expired. These are engineering rules to consider, not findings that your present code necessarily does these things. [§1.12]

**A useful distinction is: improve observation coverage without forcing execution.** The scanner may evaluate more eligible opportunities within its resource budget, while the execution layer remains selective. A missed qualifying signal and a correctly rejected trade are different outcomes and should have different diagnostics. [§1.13]

## 2. What actually changes when the LLM writes code

My assessment is that the wording matters most **where the specification leaves gaps**. “Maximise profits” leaves the coder to choose the profit measure, time horizon, sizing policy and treatment of risk. “Optimise the system” leaves even more interpretations open. Neither phrase is an acceptance test. Anthropic’s own guidance recommends replacing vague success descriptions with measurable criteria and task-specific evaluations, including edge cases. ([platform.claude.com](https://platform.claude.com/docs/en/test-and-evaluate/develop-tests)) [§1.14]

Your survival contract already requires a **deterministic, zero-LLM trading and monitoring path**. Consequently, distinguish the LLM acting as a software author from the deployed trading engine. The intended runtime controls are implemented calculations, comparisons and state transitions, not the reassuring connotations of the original prompt. Whether the current code actually enforces that requirement was outside this document review. fileciteturn2file0L2-L2 [§1.15]

For your purpose, I would replace the slogan with this proposed wording: [§1.16]

> Seek the strongest conservatively estimated net-of-cost performance within explicitly defined capital-preservation and evidence constraints. Do not pursue trade count, win rate or hypothetical peak profit as standalone objectives. Permit no trade when qualifying evidence is absent. [§1.17]

That still leaves necessary decisions: performance **per trade or over a fixed period**, which risk limits apply, which data estimate the objective, and which untouched data test it. Those choices should be explicit before coding, rather than silently supplied by the LLM. [§1.18]

## 3. The quoted numbers do not, by themselves, establish an edge

There is an important issue in the original remediation plan. Its expectancy calculation uses the planned `minRR` directly as the winning payoff, assumes a losing payoff of `1R`, and has no explicit transaction-cost deduction. That is a simplified model, not a general demonstration of realised net expectancy. The survival contract subsequently calls for net-of-cost R and a bootstrap lower-bound gate. fileciteturn1file0L2-L2 fileciteturn8file0L2-L2 [§1.19]

For illustration, define \(R\) as the initial monetary risk of a trade. Assume a 25% win probability, every losing trade loses exactly \(1R\), and average transaction costs are \(C\), expressed in R units. Then: [§1.20]

\[
E_{\text{net}}=p\times\text{average winning R}-(1-p)\times\text{average losing R}-C
\]

| Assumed average realised winner | Expectancy at 25% wins, before costs | Exceeds \(+0.15R\)? |
|---|---:|---|
| \(2.8R\) | \(-0.050R\) | No. [§1.21] |
| \(3.5R\), the document’s default target | \(+0.125R\) | No, even before costs. [§1.22] |
| \(4.0R\), an illustrative alternative | \(+0.250R\) | Before costs, yes; after costs, it depends. [§1.23] |

These are calculator-checked illustrations, not measurements of your bot. They show why **a 25% win rate is not inherently negative expectancy**, and why **`minRR >= 2.8` does not imply `E > 0.15R`**. At an actual average winner of \(2.8R\) and average loser of \(1R\), the win probability must exceed approximately **30.26% before costs** to exceed \(+0.15R\). [§1.24]

Crucially, **planned reward-to-risk is not the same as average realised winning return**. Partial exits, trailing stops and execution outcomes must be reflected in the measured distribution. Nor should the coder assume that moving the target farther away preserves the same win probability. Costs already reflected in execution prices must not be deducted twice. [§1.25]

Therefore, I would not retain the causal wording “maximising trade frequency caused negative expectancy at a 25% win rate” without supporting trade-level analysis. Under the simplified model, frequency magnifies an existing positive or negative expectation; the win/loss payoffs and costs determine its sign. The historical causal claim remains unverified here. [§1.26]

## 4. Specific contract ambiguities that matter more than the adjectives

**The expectancy gate is not consistently specified.** The survival document uses `E > 0.15R` in one place, but `expectancyLowerR >= 0.15R` in another. A point estimate and a lower confidence estimate are not interchangeable; neither are `>` and `>=` at the boundary. Also, a threshold establishes eligibility, not what to optimise among eligible alternatives. The coding LLM should flag these differences rather than silently choose one. fileciteturn7file0L2-L2 fileciteturn8file0L2-L2 [§1.27]

**“Survival” needs its own definition.** Positive average expectancy alone does not specify an acceptable drawdown, exposure concentration, loss sequence or capital-depletion probability. The risk-constrained Kelly research is relevant precisely because it treats growth and drawdown risk as separate requirements. For your contract, `E > 0.15R` should not be presented as a survival guarantee. ([web.stanford.edu](https://web.stanford.edu/~boyd/papers/kelly.html)) [§1.28]

**Notional exposure must not be confused with loss-at-stop risk.** The remediation plan explicitly caps USD *notional exposure* at 1.5% of balance. That is a different quantity from risking 1.5% of balance between entry and stop loss. I am not recommending changing that number; I am flagging that an LLM must not silently reinterpret its meaning. fileciteturn1file0L2-L2 [§1.29]

**Biomimicry is inspiration, not validation of trading outcomes.** The survival contract labels some inferences “Derived & Validated” and uses language such as “guaranteeing premature stop-outs”. I have not verified trading evidence supporting those assertions. Biological analogy can motivate a candidate mechanism; it does not, by itself, establish that the proposed mechanism improves this bot’s results. fileciteturn8file0L2-L2 [§1.30]

A related example is the promise that a latched stop “never” realises a net-of-fee loss. **Code can constrain the stop price it requests; it cannot guarantee the market’s execution price.** cTrader documents that a triggered stop loss closes at the best available market price, and that spread, commission and slippage can affect the net result. The enforceable requirement should concern valid stop placement, acknowledgement, reconciliation and stress-tested execution assumptions, not an unconditional no-loss promise. fileciteturn8file0L2-L2 ([help.ctrader.com](https://help.ctrader.com/trading-with-ctrader/orders/?utm_source=chatgpt.com)) [§1.31]

## 5. Suggested instruction for your coding LLM

This is a **review-only prompt**, not an instruction to change your repository or activate trading. It makes the intended distinction operational without inventing new risk limits. [§1.32]

```text
Review the current repository instructions and both Biomimicry contracts.
Do not edit files, deploy, change configuration, or alter trading states.

Interpret “optimise” as seeking a defined objective within hard constraints.
“Maximise” is permissible only when the quantity and constraints are explicit.
Treat “FOMO” as a label for prohibited behaviours, not a mathematical objective.

Before proposing code:

1. Separate:
   - the objective to improve;
   - eligibility thresholds;
   - hard safety constraints;
   - diagnostic metrics.
   State each metric's units, time horizon and data source.

2. Flag conflicting definitions, including:
   - expected R versus bootstrap lower-bound expected R;
   - > 0.15 versus >= 0.15;
   - planned reward-to-risk versus realised payoff distribution;
   - notional exposure versus monetary loss-at-stop risk.
   Do not silently resolve them or invent missing thresholds.

3. Define R consistently from original verified entry risk.
   Account for partial exits and applicable costs exactly once.
   Do not improve reported performance by changing the denominator,
   excluding losses, assuming fills, or using future information.

4. Propose tests preventing entry-gate relaxation merely because trading
   activity is low. Distinguish legitimate no-trade decisions from broken
   signal delivery. Missing evidence must not authorise new exposure;
   protective handling of existing positions must remain available.

5. Separate parameter selection from untouched chronological confirmation.
   Report the search performed and all relevant failures.
   Treat biological analogies and unvalidated settings as hypotheses.

Return a requirement-to-code-to-test mapping, unresolved decisions, and
Passed / Failed / Not Verifiable evidence. Stop before implementation.
```

**Bottom line: do not rely on “optimise” to make the LLM prudent, or treat “maximise” as inherently reckless. Specify what may improve, what may never be traded away to improve it, and what happens when evidence is insufficient.** For this system, “no qualifying trade” must remain a valid outcome, while the diagnostic layer checks whether that outcome is genuine or caused by a fault. [§1.33]

**Evidence check:** Matching passage - **Passed**, located in the pinned GitHub document. Illustrative arithmetic - **Passed**, checked with the calculator. Specification consistency - **Failed**, the expectancy definitions and boundary comparisons differ as described above. Runtime enforcement and profitable edge - **Not Verifiable**, because this review did not inspect executable implementations, run repository tests or reconcile broker records. GitHub access was read-only; no files, deployments, settings or trades were changed. [§1.34]

**AI NOTE:** The weakest stage is **Interpretation**. The cheapest fix is **Step-Back**: require the agent to distinguish the objective, constraints and diagnostics before proposing code. Then use a **Verification loop** to test the boundary cases, rather than treating a persuasive explanation as evidence. [§1.35]
<!-- END ORIGINAL RESPONSE -->

---

**Source-link supplement - not part of the original response**

The original chat-specific citation markers are retained verbatim above. For standalone use:

- `turn2file0`, `turn7file0` and `turn8file0` refer to [bot_trade_biomimetic_survival_contract.md](https://github.com/ang-kl/bot-trade/blob/42bbabc011106b291036cf1ad0d99c1dd5e078d4/doc/Biomimicry/bot_trade_biomimetic_survival_contract.md).
- `turn1file0` refers to [bot_trade_remediation_plan_aligned.md](https://github.com/ang-kl/bot-trade/blob/42bbabc011106b291036cf1ad0d99c1dd5e078d4/doc/Biomimicry/bot_trade_remediation_plan_aligned.md).

These links use the pinned repository snapshot identified in the original response, rather than the changing `main` branch. The six original web-link occurrences remain in their original positions in the response.
